This week’s case study reviews the PTEN genetic testing from a 34-year-old female who presented to a dermatology clinic for evaluation of several facial skin lesions. Can you make the diagnosis?
In the United States, Lyme disease is caused by “Borrelia burgdorferi” and “Borrelia mayonii” bacteria, carried primarily by “black-legged” or “deer ticks.” To learn more about Lyme disease, the Mayo Clinic Department of Laboratory Medicine and Pathology and its reference laboratory Mayo Medical Laboratories have developed “The ABCs of Lyme Disease” flash cards.
In this month’s “Hot Topic,” Ariela Marshall, M.D., provides an overview of venous thromboembolism in the pregnant population, including its risk factors, treatment, and prevention.
This program’s overall objective is to update the practicing hematologists/oncologists and hematopathologists about the evolving repertoire of test options and appropriate testing strategies.
Wednesday, August 9 | 11 a.m.–noon CT
An educational overview of the large category of peripheral neuropathies, discussing various testing platforms strengths and weaknesses, with a focus on identifying hereditary neuropathies.
Wednesday, August 30 | Noon–1 p.m. CT
This presentation offers an educational overview of next-generation sequencing (NGS) testing for hematologic malignancies, specifically myeloid disorders and multiple myeloma.
Diabetes mellitus type 1 accounts for most juvenile-onset diabetes. This disease is easily identified by testing for 4 antibodies, and the antibodies can even be detected before the patient becomes symptomatic. A new diabetes evaluation is now available to help detect disease, differentiate between diabetes type 1 and type 2, and aid in the risk assessment for future diabetes risk.